Computational Discovery of Putative Leads for Drug Repositioning through Drug-Target Interaction Prediction.
De novo experimental drug discovery is an expensive and time-consuming task. It requires the identification of drug-target interactions (DTIs) towards targets of biological interest, either to inhibit or enhance a specific molecular function. Dedicated computational models for protein simulation and...
Main Authors: | Edgar D Coelho, Joel P Arrais, José Luís Oliveira |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-11-01
|
Series: | PLoS Computational Biology |
Online Access: | http://europepmc.org/articles/PMC5125559?pdf=render |
Similar Items
-
Accelerating antimalarial drug discovery through repositioning
by: Matthews, H.
Published: (2013) -
Prediction of drug-target interactions and drug repositioning via network-based inference.
by: Feixiong Cheng, et al.
Published: (2012-01-01) -
Old drug repositioning and new drug discovery through similarity learning from drug-target joint feature spaces
by: Yi Zheng, et al.
Published: (2019-12-01) -
Repositioning Natural Products in Drug Discovery
by: Giulio Rastelli, et al.
Published: (2020-03-01) -
Using synthetic lethality to predict therapeutic biomarkers for drug repositioning and drug discovery
by: Kun-Lin Chuang, et al.
Published: (2018)